PrecisionLife licenses OXEGENE dataset to develop personalized treatments for endometriosis

FHS
July 10, 2023
6:01 am

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.

#ASCO24: Novartis’ new CML treatment tops older drugs, including Gleevec, in Phase 3 trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 1, 2024

Adaptation and utilization of digital contact tracing applications in the post-pandemic period

During the pandemic, contact tracing apps kept Americans informed of potential exposure risk with the goal of reducing infections.

June 21, 2023

Opinion | The Early Days of the AIDS Crisis Felt Like ‘Putting Band-Aids on a Hemorrhage’

Fauci is the former director of the National Institute of Allergy and Infectious Diseases (NIAID). I think of the years from 1982 until the late

July 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.